Health Invest Partners Ab Alkermes Plc. Transaction History
Health Invest Partners Ab
- $160 Million
- Q2 2024
A detailed history of Health Invest Partners Ab transactions in Alkermes Plc. stock. As of the latest transaction made, Health Invest Partners Ab holds 68,800 shares of ALKS stock, worth $1.95 Million. This represents 1.04% of its overall portfolio holdings.
Number of Shares
68,800Holding current value
$1.95 Million% of portfolio
1.04%Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
349Shares Held
183MCall Options Held
209KPut Options Held
89.4K-
Black Rock Inc. New York, NY29.1MShares$826 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$567 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.4MShares$407 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$312 Million0.03% of portfolio
-
State Street Corp Boston, MA9.22MShares$261 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.66B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...